Quest Diagnostics donates to humanitarian efforts in Ukraine

LabPulse.com staff writers
Mar 14, 2022
2022 03 15 14 11 6990 Hands Diverse Teamwork 400

The Quest Diagnostics Foundation has donated $500,000 to Project Health Opportunities for People Everywhere (HOPE) to aid humanitarian crisis relief for Ukraine and for Ukrainian refugees in Eastern Europe.

In addition, the foundation has matched donations from Quest Diagnostics employees to Project HOPE.

Latest in Infectious
3 D Monkeypox Infecting Cell Social
WHO approves Abbott mpox test for emergency use
October 4, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Roche Aacc 2019 Social
Roche launches diagnostic test for 12 respiratory viruses
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
Cepheid partners with Fleming Initiative on antimicrobial resistance
September 26, 2024
Related Stories
Ukrainian Flag Red Cross Social
Infectious
War raises infectious diseases in Ukraine to alarming levels
Business Network Concept
Trends and Finance
Quest Diagnostics announces leadership organizational changes
2021 02 25 23 48 3444 Covid Virus Dna Molecule 400
Sequencing
Quest reports COVID-19 test demand rose in May
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Infectious
WHO approves Abbott mpox test for emergency use
By LabPulse.com staff writers
The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.
October 4, 2024
3 D Monkeypox Infecting Cell Social
Abionic sepsis test gets FDA 510(k) clearance
By LabPulse.com staff writers
Abionic, a diagnostics firm specializing in rapid early detection, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IVD Capsule PSP test for sepsis.
October 3, 2024
Fda Button Social
Roche launches diagnostic test for 12 respiratory viruses
By LabPulse.com staff writers
Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.
September 26, 2024
Roche Aacc 2019 Social
Cepheid partners with Fleming Initiative on antimicrobial resistance
By LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
FDA clears marketing T2 Biosystems Candida test for pediatrics
By LabPulse.com staff writers
T2Candida Panel may get a boost.
September 16, 2024
Candida Candidiasis Social
LuminUltra acquires Genomadix Legionella test assets
By LabPulse.com staff writers
LuminUltra has acquired the Legionella testing business assets of Genomadix, as well as the rights to develop and commercialize further assays and test methods.
September 10, 2024
Water Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
AI-guided rapid Lyme disease test shows promise for early detection
By LabPulse.com staff writers
A new test under development that uses artificial intelligence (AI) and a format similar to that of at-home COVID-19 tests has been shown to accurately identify Lyme disease within 20 minutes.
August 29, 2024
Ticks Sign Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
BioMérieux receives 510(k) certification for antimicrobial testing system
By LabPulse.com staff writers
BioMérieux has received 510(k) clearance from the U.S. Food and Drug Administration for its Vitek Reveal AST system, which reports antimicrobial susceptibility testing (AST) results directly from positive blood cultures.
August 21, 2024
Sepsis Bacteria Social
Page 1 of 152
Next Page